SPIB is a novel prognostic factor in diffuse large B-cell lymphoma that mediates apoptosis via the PI3K-AKT pathway
about
Risk analysis of colorectal cancer incidence by gene expression analysis.Expressions Profiles of the Proteins Associated with Carbohydrate Metabolism in Rat Liver Regeneration.Bortezomib prevents cytarabine resistance in MCL, which is characterized by down-regulation of dCK and up-regulation of SPIB resulting in high NF-κB activity.
P2860
SPIB is a novel prognostic factor in diffuse large B-cell lymphoma that mediates apoptosis via the PI3K-AKT pathway
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 June 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
SPIB is a novel prognostic fac ...... tosis via the PI3K-AKT pathway
@en
SPIB is a novel prognostic fac ...... osis via the PI3K-AKT pathway.
@nl
type
label
SPIB is a novel prognostic fac ...... tosis via the PI3K-AKT pathway
@en
SPIB is a novel prognostic fac ...... osis via the PI3K-AKT pathway.
@nl
prefLabel
SPIB is a novel prognostic fac ...... tosis via the PI3K-AKT pathway
@en
SPIB is a novel prognostic fac ...... osis via the PI3K-AKT pathway.
@nl
P2093
P2860
P356
P1433
P1476
SPIB is a novel prognostic fac ...... tosis via the PI3K-AKT pathway
@en
P2093
Akihiro Tomita
Fumihiko Hayakawa
Hitoshi Kiyoi
Kazuyuki Shimada
Satoko Shimada
Shigeo Nakamura
Tomoki Naoe
P2860
P304
P356
10.1111/CAS.13001
P577
2016-09-06T00:00:00Z